DOCSLIB.ORG

Histidine in Health and Disease: Metabolism, Physiological Importance, and Use As a Supplement

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Histidine in Health and Disease: Metabolism, Physiological Importance, and Use As a Supplement nutrients Review Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement Milan Holeˇcek Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University, Šimkova 870, 500 38 Hradec Kralove, Czech Republic; [email protected] Received: 7 February 2020; Accepted: 20 March 2020; Published: 22 March 2020 Abstract: L-histidine (HIS) is an essential amino acid with unique roles in proton buffering, metal ion chelation, scavenging of reactive oxygen and nitrogen species, erythropoiesis, and the histaminergic system. Several HIS-rich proteins (e.g., haemoproteins, HIS-rich glycoproteins, histatins, HIS-rich calcium-binding protein, and filaggrin), HIS-containing dipeptides (particularly carnosine), and methyl- and sulphur-containing derivatives of HIS (3-methylhistidine, 1-methylhistidine, and ergothioneine) have specific functions. The unique chemical properties and physiological functions are the basis of the theoretical rationale to suggest HIS supplementation in a wide range of conditions. Several decades of experience have confirmed the effectiveness of HIS as a component of solutions used for organ preservation and myocardial protection in cardiac surgery. Further studies are needed to elucidate the effects of HIS supplementation on neurological disorders, atopic dermatitis, metabolic syndrome, diabetes, uraemic anaemia, ulcers, inflammatory bowel diseases, malignancies, and muscle performance during strenuous exercise. Signs of toxicity, mutagenic activity, and allergic reactions or peptic ulcers have not been reported, although HIS is a histamine precursor. Of concern should be findings of hepatic enlargement and increases in ammonia and glutamine and of decrease in branched-chain amino acids (valine, leucine, and isoleucine) in blood plasma indicating that HIS supplementation is inappropriate in patients with liver disease. Keywords: histidine supplementation; HTK solution; carnosine; beta-alanine; ammonia; glutamine; branched-chain amino acids; Bretschneider’s solution 1. Introduction and Aims L-Histidine (HIS) is a nutritionally essential amino acid (EAA) with unique biochemical and physiological properties, which have created a good theoretical rationale to suggest the use of HIS as a nutritional supplement in a wide range of conditions. Initially, HIS was shown to treat rheumatoid arthritis and anaemia in patients with chronic renal failure [1,2]. Currently, HIS and/or HIS-containing dipeptides (HIS-CD) are investigated to prevent fatigue during strenuous exercise and for therapy in ageing-related disorders, metabolic syndrome, atopic dermatitis, ulcers, inflammatory bowel diseases, ocular diseases, and neurological disorders [3–9]. The first aim of the article is to provide an overview of main pathways of HIS metabolism; chemical and biological properties of HIS, such as proton buffering, metal ion chelation, and antioxidant functions; and a role of several proteins and peptides containing large amounts of HIS residues, such as carnosine (CAR), filaggrin, and histatins. With this explanation as a background, the results of studies examining the benefits and therapeutic potential of HIS and HIS-CD will be discussed or reviewed. Nutrients 2020, 12, 848; doi:10.3390/nu12030848 www.mdpi.com/journal/nutrients Nutrients 2020, 12, 848 2 of 20 Nutrients 2020, 12, x FOR PEER REVIEW 2 of 19 2. Histidine, Chemical, and Biological Properties The unique chemical properties of HIS, which are mainly attributed to the imidazole ring (Figure The unique chemical properties of HIS, which are mainly attributed to the imidazole ring 1), include proton buffering, metal ion chelation, and antioxidant activities. These cytoprotective (Figure1), include proton bu ffering, metal ion chelation, and antioxidant activities. These cytoprotective interactions may involve free HIS, HIS-containing peptides, HIS-CD, and HIS residues in proteins. interactions may involve free HIS, HIS-containing peptides, HIS-CD, and HIS residues in proteins. Figure 1. Histidine structure: histidine (HIS) contains an α-amino group, a carboxylic acid group, Figureand an 1. imidazole Histidine side structure: chain. histidine Under physiological (HIS) contains conditions, an α-amino the group, amino a group carboxylic is protonated acid group, and and the ancarboxylic imidazole group side is chain. deprotonated. Under physiological The imidazole co ringnditions, is responsible the amino for thegroup proton is protonated buffering, metal and the ion carboxylicchelating, andgroup antioxidant is deprotonated. properties. The imidazole ring is responsible for the proton buffering, metal ion chelating, and antioxidant properties. 2.1. HIS as a pH Buffer 2.1. HIS as a pH Buffer Of all the amino acid side chains in proteins, only the imidazole ring of HIS is suitable to function as a pHOf buffer all the [10 amino], and eitheracid side of the chains two nitrogensin proteins, of theonly imidazole the imidazole ring can ring bind of HIS or release is suitable a proton to function to form asthe a acidpH buffer or the base[10], form.and either The pKaof the values two nitrogens of imidazole of the group imidazole of free L-HISring can are bind 6.2 and or release 6.5 when a proton bound toin proteins,form the 7.0acid in or CAR, the base and 7.1form. in anserine The pKa [ 11values]. Therefore, of imidazole HIS-CD, group such of as free CAR L-HIS and anserine,are 6.2 and act 6.5 as whenpowerful bound buffers in proteins, and attenuate 7.0 in changesCAR, and in 7.1 intracellular in anserine pH [11]. in musclesTherefore, during HIS-CD, anaerobic such exerciseas CAR and [11]. anserine,The role of act HIS as as powerful an efficient buffers H+ buffer and enablesattenuate use changes of HIS as in a componentintracellular of pH solutions in muscles employed during for anaerobicorgan preservation exercise [11]. before The transplantation role of HIS as andan efficient myocardial H+ buffer protection enables in cardiac use of HIS surgery as a [component12–14]. of solutions employed for organ preservation before transplantation and myocardial protection in cardiac2.2. HIS surgery and Metal [12–14]. Ion Chelation Several studies have reported the ability of HIS and HIS-CD, particularly CAR, and HIS-rich 2.2.proteins HIS and to formMetal complexes Ion Chelation with metal ions, such as Fe2+, Cu2+, Co2+, Ni2+, Cd2+, and Zn2+ [15,16]. Specifically,Several HISstudies is responsible have reported for bindingthe ability of ironof HIS in haemoglobin and HIS-CD, and particularly myoglobin CAR, molecules and HIS-rich and is proteinsfrequently to presentform complexes in the active with sites metal of metalloenzymes, ions, such as Fe such2+, Cu as2+, carbonicCo2+, Ni2+ anhydrase,, Cd2+, and cytochromes, Zn2+ [15,16]. Specifically,heme peroxidases, HIS is nitricresponsible oxide synthase,for binding and of catalases,iron in haemoglobin where plays and a role myoglobin in regulating molecules their activity. and is frequentlyHistidine-rich present glycoprotein in the active present sites in of plasma metalloen of vertebrateszymes, such interacts as carbonic with anhydrase, many ligands, cytochromes, including hemezinc, hasperoxidases, an important nitric role oxide in immunity synthase, [and15]. catalases, where plays a role in regulating their activity. Histidine-richSeveral metal glycoprotein ions promote present the in production plasma of of vertebrates free radicals interacts through with the many Fenton ligands, reaction including [17] and zinc,exert has toxic an e importantffects on organism, role in immunity which can [15]. be attenuated by HIS or HIS-CD. It has been proven that CARSeveral protects metal against ions copper- promote and the zinc-induced production neurotoxicityof free radicals [18 through]. the Fenton reaction [17] and exert toxic effects on organism, which can be attenuated by HIS or HIS-CD. It has been proven that 2.3. HIS as an Antioxidant CAR protects against copper- and zinc-induced neurotoxicity [18]. The antioxidant activity of HIS is mediated by metal ion chelation (see above), by the scavenging 2.3.of reactive HIS as an oxygen Antioxidant (ROS) and nitrogen (RNS) species, and by sequestering advanced glycation (AGE; e.g., glyoxalThe antioxidant and methylglyoxal) activity of HIS and is advanced mediated lipoxidation by metal ion (ALE; chelation e.g., malondialdehyde(see above), by the and scavenging acrolein) ofend reactive products oxygen [19–24 (ROS)]. High and concentrations nitrogen (RNS) of species, AGE/ALE and are by recognizedsequestering as advanced noxious factors glycation related (AGE; to e.g.,various glyoxal complications, and methylglyoxal) notably, microangiopathy and advanced and lipoxidation retinopathy (ALE; of diabetes e.g., [malondialdehyde23]. and acrolein)HIS-CD, end products particularly [19–24]. CAR, High is more concentrations effective ROS of AGE/ALE/RNS and are AGE recognized/ALE scavengers as noxious than factors free relatedHIS [19 ,to20 various]. The underlying complications, mechanisms notably, of micr the antioxidantoangiopathy e ffandects retinopathy of imidazole-containing of diabetes [23]. compounds remainHIS-CD, obscure particularly [25]. CAR, is more effective ROS/RNS and AGE/ALE scavengers than free HIS [19,20]. The underlying mechanisms of the antioxidant effects of imidazole-containing compounds remain obscure [25]. 3. HIS Requirements and Sources 3.1. Effects of a HIS-deficient Diet Nutrients 2020, 12, 848 3 of 20 3. HIS Requirements and Sources 3.1. Effects of a HIS-Deficient Diet
Load more

Recommended publications
  • Ergothioneine As an Anti-Oxidative/Anti-Inflammatory Component in Several Edible Mushrooms
    Food Sci. Technol. Res., 17 (2), 103–110, 2011 Ergothioneine as an Anti-Oxidative/Anti-Inflammatory Component in Several Edible Mushrooms 1* 2 3 4 2 2 Tomomi ito , Manami Kato , Hironobu tsuchida , Etsuko harada , Toshio niwa and Toshihiko osawa 1 Hokkaido University of Education Asahikawa Campus, 9-Hokumoncho, Asahikawa 070-8621, Japan 2 Nagoya University Graduate School of Bioagricultural Sciences, Furo-cho, Chikusa, Nagoya 464-8601, Japan 3 Aichi Mizuho College, 86-1, Haiwa, Hiratobashi-cho, Toyota, Aichi 470-0394, Japan 4 Iwade Research Institute of Mycology, Tsu, Mie 514-0012, Japan Received May 8, 2010; Accepted December 1, 2010 We measured the anti-oxidative and anti-inflammatory activities of hot water extracts prepared from 11 species of mushrooms. Anti-oxidative activity was evaluated using the oxygen radical absorbance capacity method, and anti-inflammatory activity was examined by measuring the inhibition of lysine chloramine formation by hypochlorous acid. Hot water extracts of Grifola gargal (G. gargal) showed the strongest anti-oxidative activity and inhibitory effects on lysine chloramines. Hot water extracts of G. gargal were evaluated by HPLC and divided into 8 fractions. The most active fraction among these 8 frac- tions was further purified by preparative HPLC. The active component isolated by HPLC was identified as ergothioneine (EGT) using spectral analysis. On HPLC analysis, the EGT content in G. gargal was the highest among the 11 species of mushrooms. We also examined the protective role of EGT by examining the
    [Show full text]
  • Neurotransmitter Resource Guide
    NEUROTRANSMITTER RESOURCE GUIDE Science + Insight doctorsdata.com Doctor’s Data, Inc. Neurotransmitter RESOURCE GUIDE Table of Contents Sample Report Sample Report ........................................................................................................................................................................... 1 Analyte Considerations Phenylethylamine (B-phenylethylamine or PEA) ................................................................................................. 1 Tyrosine .......................................................................................................................................................................................... 3 Tyramine ........................................................................................................................................................................................4 Dopamine .....................................................................................................................................................................................6 3, 4-Dihydroxyphenylacetic Acid (DOPAC) ............................................................................................................... 7 3-Methoxytyramine (3-MT) ............................................................................................................................................... 9 Norepinephrine ........................................................................................................................................................................
    [Show full text]
  • Effects of Dietary L-Glutamine Or L-Glutamine Plus L-Glutamic Acid
    Brazilian Journal of Poultry Science Revista Brasileira de Ciência Avícola Effects of Dietary L-Glutamine or L-Glutamine Plus ISSN 1516-635X Oct - Dec 2015 / Special Issue L-Glutamic Acid Supplementation Programs on the Nutrition - Poultry feeding additives / 093-098 Performance and Breast Meat Yield Uniformity of http://dx.doi.org/10.1590/1516-635xSpecialIssue 42-d-Old Broilers Nutrition-PoultryFeedingAdditives093-098 Author(s) ABSTRACT Ribeiro Jr VIII This study aimed at evaluating four dietary L-Glutamine (L-Gln) Albino LFTI or L-Gln plus L-Glutamate (L-Glu) supplementation programs on the Rostagno HSI Hannas MII performance, breast yield, and uniformity of broilers. A total of 2,112 Ribeiro CLNIII one-d-old male Cobb 500® broilers were distributed according to a Vieira RAIII randomized block design in a 2 × 4 factorial arrangement (L-Gln or L-Gln Araújo WAG deIV Pessoa GBSII plus L-Glu × 4 supplementation programs), totaling eight treatments Messias RKGIII with 12 replicates of 22 broilers each. The supplementation programs Silva DL daIII consisted of the dietary inclusion or not of 0.4% of L-Gln or L-Gln plus L-Glu for four different periods: 0 days (negative control), 9d, 21d, and 42d. Feed intake (FI, g), body weight gain (BWG, g), feed conversion I Federal University of Viçosa, Department ratio (FCR, kg/kg), coefficient of variation of body weight (CV, %), body of Animal Science, Av PH Rolfs S/N, Viçosa 36570-000, MG, Brazil weight uniformity (UNIF, %), breast weight (BW, g), breast yield (BY, II Ajinomoto do Brasil Ind. e Com. de %), coefficient of variation of breast weight (CVB), breast uniformity Alimentos Ltda.
    [Show full text]
  • Amino Acids, Glutamine, and Protein Metabolism in Very Low Birth Weight Infants
    0031-3998/05/5806-1259 PEDIATRIC RESEARCH Vol. 58, No. 6, 2005 Copyright © 2005 International Pediatric Research Foundation, Inc. Printed in U.S.A. Amino Acids, Glutamine, and Protein Metabolism in Very Low Birth Weight Infants PRABHU S. PARIMI, MARK M. KADROFSKE, LOURDES L. GRUCA, RICHARD W. HANSON, AND SATISH C. KALHAN Department of Pediatrics, Schwartz Center for Metabolism and Nutrition, Case Western Reserve University School of Medicine, MetroHealth Medical Center, Cleveland, Ohio, 44109 ABSTRACT Glutamine has been proposed to be conditionally essential for 5 h (AA1.5) resulted in decrease in rate of appearance (Ra) of premature infants, and the currently used parenteral nutrient phenylalanine and urea, but had no effect on glutamine Ra. mixtures do not contain glutamine. De novo glutamine synthesis Infusion of amino acids at 3.0 g/kg/d for 20 h resulted in increase (DGln) is linked to inflow of carbon into and out of the tricar- in DGln, leucine transamination, and urea synthesis, but had no boxylic acid (TCA) cycle. We hypothesized that a higher supply effect on Ra phenylalanine (AA-Ext). These data show an acute of parenteral amino acids by increasing the influx of amino acid increase in parenteral amino acid–suppressed proteolysis, how- carbon into the TCA cycle will enhance the rate of DGln. Very ever, such an effect was not seen when amino acids were infused low birth weight infants were randomized to receive parenteral for 20 h and resulted in an increase in glutamine synthesis. amino acids either 1.5 g/kg/d for 20 h followed by 3.0 g/kg/d for (Pediatr Res 58: 1259–1264, 2005) 5 h (AA1.5) or 3.0 g/kg/d for 20 h followed by 1.5 g/kg/d for 5 h (AA3.0).
    [Show full text]
  • Diphenhydramine Hydrochloride (CASRN 147-24-0) in F344/N Rats
    NATIONAL TOXICOLOGY PROGRAM Technical Report Series No. 355 TOXICOLOGY AND CARCINOGENESIS STUDIES OF DIPHENHYDRAMINE HYDROCHLORIDE (CAS NO. 147-24-0) IN F344/N RATS AND B6C3F1 MICE (FEED STUDIES) LJ.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health NTP ‘TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF DIPHENHYDRAMINE HYDROCHLORIDE (CAS NO. 147-24-0) IN F344/N RATS AND B6C3F1 MICE (FEED STUDIES) R. Melnick, Ph.D., Study Scientist NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 September 1989 NTP TR 355 NIH Publication No. 89-2810 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health CONTENTS PAGE ABSTRACT ................................................................ 3 EXPLANATION OF LEVELS OF EVIDENCE OF CARCINOGENIC ACTIVITY .................. 6 CONTRIBUTORS ............................................................ 7 PEERREVIEWPANEL ........................................................ 8 SUMMARY OF PEER REVIEW COMMENTS ......................................... 9 I. INTRODUCTION ........................................................ 11 I1. MATERIALS AND METHODS .............................................. 21 III. RESULTS ............................................................. 35 RATS ............................................................. 36 MICE ............................................................. 45 GENETIC TOXICOLOGY ............................................... 53 IV.
    [Show full text]
  • Metabolomics Analysis of Skeletal Muscles from FKRP-Deficient Mice
    www.nature.com/scientificreports OPEN Metabolomics Analysis of Skeletal Muscles from FKRP-Defcient Mice Indicates Improvement After Gene Received: 21 March 2019 Accepted: 28 June 2019 Replacement Therapy Published: xx xx xxxx Charles Harvey Vannoy 1, Victoria Leroy1, Katarzyna Broniowska2 & Qi Long Lu1 Muscular dystrophy-dystroglycanopathies comprise a heterogeneous and complex group of disorders caused by loss-of-function mutations in a multitude of genes that disrupt the glycobiology of α-dystroglycan, thereby afecting its ability to function as a receptor for extracellular matrix proteins. Of the various genes involved, FKRP codes for a protein that plays a critical role in the maturation of a novel glycan found only on α-dystroglycan. Yet despite knowing the genetic cause of FKRP-related dystroglycanopathies, the molecular pathogenesis of disease and metabolic response to therapeutic intervention has not been fully elucidated. To address these challenges, we utilized mass spectrometry- based metabolomics to generate comprehensive metabolite profles of skeletal muscle across diseased, treated, and normal states. Notably, FKRP-defcient mice elicit diverse metabolic abnormalities in biomarkers of extracellular matrix remodeling and/or aging, pentoses/pentitols, glycolytic intermediates, and lipid metabolism. More importantly, the restoration of FKRP protein activity following AAV-mediated gene therapy induced a substantial correction of these metabolic impairments. While interconnections of the afected molecular mechanisms remain unclear,
    [Show full text]
  • Role of Dietary Histidine in the Prevention of Obesity and Metabolic Syndrome
    Open access Editorial Open Heart: first published as 10.1136/openhrt-2017-000676 on 1 July 2018. Downloaded from Role of dietary histidine in the prevention of obesity and metabolic syndrome James J DiNicolantonio,1 Mark F McCarty,2 James H OKeefe 1 To cite: DiNicolantonio JJ, HISTIDINE SUPPLEMENTATION AMELIORATES histidine dose dependently increases hypo- McCarty MF, OKeefe JH. Role of METABOLIC SYNDROME thalamic levels of histamine as well as hypo- dietary histidine in the prevention of obesity and A recent Chinese supplementation study, in thalamic activity of histidine decarboxylase, metabolic syndrome. Open Heart which obese middle-aged women diagnosed the enzyme which converts histidine to hista- 10 2018;5:e000676. doi:10.1136/ with metabolic syndrome received 12 weeks mine. Such administration also inhibits food openhrt-2017-000676 of supplemental histidine (2 g, twice daily) or consumption—an effect that is blocked in matching placebo, achieved remarkable find- animals pretreated with an irreversible inhib- 1 Accepted 24 April 2018 ings. Insulin sensitivity improved significantly itor of histidine decarboxylase. in the histidine-supplemented subjects, and Neuronal histamine release in the hypo- this may have been partially attributable to thalamus is subject to feedback regulation loss of body fat. Body mass index (BMI), waist by presynaptic H3 receptors. In rodent circumference and body fat declined in the studies, antagonists and inverse agonists for histidine-supplemented group relative to the these receptors have been shown to mark- placebo group; the average fat loss in the histi- edly amplify hypothalamic histamine levels, dine group was a robust 2.71 kg. Markers of suppress feeding, decrease body weight and systemic inflammation such as serum tumour enhance metabolic rate.11–15 Such agents may necrosis factor-alpha (TNF-α) and inter- have clinical potential for managing obesity.
    [Show full text]
  • Histidine Decarboxylase Knockout Mice Production and Signal
    Nitric Oxide Mediates T Cell Cytokine Production and Signal Transduction in Histidine Decarboxylase Knockout Mice This information is current as Agnes Koncz, Maria Pasztoi, Mercedesz Mazan, Ferenc of October 1, 2021. Fazakas, Edit Buzas, Andras Falus and Gyorgy Nagy J Immunol 2007; 179:6613-6619; ; doi: 10.4049/jimmunol.179.10.6613 http://www.jimmunol.org/content/179/10/6613 Downloaded from References This article cites 41 articles, 8 of which you can access for free at: http://www.jimmunol.org/content/179/10/6613.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on October 1, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Nitric Oxide Mediates T Cell Cytokine Production and Signal Transduction in Histidine Decarboxylase Knockout Mice1 Agnes Koncz,*† Maria Pasztoi,* Mercedesz Mazan,* Ferenc Fazakas,‡ Edit Buzas,* Andras Falus,*§ and Gyorgy Nagy2,3*¶ Histamine is a key regulator of the immune system.
    [Show full text]
  • The New Super Antioxidant, Ergothioneine in Pleurotus Ostreatus
    22 [Vol : 3 Issue : 10 | October, 2020] E-ISSN : 2410-5171 | P-ISSN 2415-1246 The International Journal of Health, Education and Social (IJHES) Literatur Review: The New Super Antioxidant, Ergothioneine In Pleurotus ostreatus Windi Permatasari1, Dilla Dayanti2, Icha Khaerunnisa3, Sri Winarni1 1 Faculty of Public Health, Diponegoro University, Semarang 2 Faculty of Science and Matemathic, Diponegoro University, Semarang 3Faculty of Medical, Diponegoro University, Semarang Email: [email protected] Article details: th sulfur group that has the potential to be a stable, safe, and Published: 30 October 2020 strong antioxidant (super antioxidant). In the health sector, ergothioneine antioxidants have the potential to prevent diseases such as cardiovascular, kidney, cancer, and inhibit the growth of tumor cells. In addition, ergothioneine also has the potential to be used as a supplement and medicine. Abstract The method used to compile this review article is a literature Pleurotus ostreatus is one of the study of indexed and leading research journals conducted mushrooms that is widely on the Google Scholar database, Science Direct, and consumed by Indonesian people. PubMed. This review article discusses the ergothioneine The easy cultivation of Pleurotus content in Pleurotus ostreatus and the health benefits of ostreatus is one of the reasons ergothioneine why Indonesian people choose Keywords: Pleurotus ostreatus, antioxidants, Pleurotus ostreatus as a ergothioneine, content and benefits ergothioneine cultivated mushroom and is it is also used as a source of income. The main reason why people consume Pleurotus ostreatus is because it tastes good. On the other hand, Pleurotus ostreatus contains many chemical compounds that are beneficial to health, one of which is a rare amino acid compound, ergothioneine.
    [Show full text]
  • Amino Acid Recognition by Aminoacyl-Trna Synthetases
    www.nature.com/scientificreports OPEN The structural basis of the genetic code: amino acid recognition by aminoacyl‑tRNA synthetases Florian Kaiser1,2,4*, Sarah Krautwurst3,4, Sebastian Salentin1, V. Joachim Haupt1,2, Christoph Leberecht3, Sebastian Bittrich3, Dirk Labudde3 & Michael Schroeder1 Storage and directed transfer of information is the key requirement for the development of life. Yet any information stored on our genes is useless without its correct interpretation. The genetic code defnes the rule set to decode this information. Aminoacyl-tRNA synthetases are at the heart of this process. We extensively characterize how these enzymes distinguish all natural amino acids based on the computational analysis of crystallographic structure data. The results of this meta-analysis show that the correct read-out of genetic information is a delicate interplay between the composition of the binding site, non-covalent interactions, error correction mechanisms, and steric efects. One of the most profound open questions in biology is how the genetic code was established. While proteins are encoded by nucleic acid blueprints, decoding this information in turn requires proteins. Te emergence of this self-referencing system poses a chicken-or-egg dilemma and its origin is still heavily debated 1,2. Aminoacyl-tRNA synthetases (aaRSs) implement the correct assignment of amino acids to their codons and are thus inherently connected to the emergence of genetic coding. Tese enzymes link tRNA molecules with their amino acid cargo and are consequently vital for protein biosynthesis. Beside the correct recognition of tRNA features3, highly specifc non-covalent interactions in the binding sites of aaRSs are required to correctly detect the designated amino acid4–7 and to prevent errors in biosynthesis5,8.
    [Show full text]
  • ACE2–Angiotensin-(1–7)–Mas Axis and Oxidative Stress in Cardiovascular Disease
    Hypertension Research (2011) 34, 154–160 & 2011 The Japanese Society of Hypertension All rights reserved 0916-9636/11 $32.00 www.nature.com/hr REVIEW SERIES ACE2–angiotensin-(1–7)–Mas axis and oxidative stress in cardiovascular disease Luiza A Rabelo1,2, Natalia Alenina1 and Michael Bader1 The renin–angiotensin–aldosterone system (RAAS) is a pivotal regulator of physiological homeostasis and diseases of the cardiovascular system. Recently, new factors have been discovered, such as angiotensin-converting enzyme 2 (ACE2), angiotensin-(1–7) and Mas. This newly defined ACE2–angiotensin-(1–7)–Mas axis was shown to have a critical role in the vasculature and in the heart, exerting mainly protective effects. One important mechanism of the classic and the new RAAS regulate vascular function is through the regulation of redox signaling. Angiotensin II is a classic prooxidant peptide that increases superoxide production through the activation of NAD(P)H oxidases. This review summarizes the current knowledge about the ACE2–angiotensin-(1–7)–Mas axis and redox signaling in the context of cardiovascular regulation and disease. By interacting with its receptor Mas, angiotensin-(1–7) induces the release of nitric oxide from endothelial cells and thereby counteracts the effects of angiotensin II. ACE2 converts angiotensin II to angiotensin-(1–7) and, thus, is a pivotal regulator of the local effects of the RAAS on the vessel wall. Taken together, the ACE2–angiotensin-(1–7)–Mas axis emerges as a novel therapeutic target in the context of cardiovascular
    [Show full text]
  • Convenient Preparation of Poly(L-Histidine) by the Direct Polymerization of L-Histidine Or Nim Benzyl-L-Histidine with Diphenylphosphoryl Azide
    Polymer Journal, Vol. 13, No. 12, pp 1151-1154 (1981) SHORT COMMUNICATION Convenient Preparation of Poly(L-histidine) by the Direct Polymerization of L-Histidine or Nim_Benzyl-L-histidine with Diphenylphosphoryl Azide Takumi NARUSE, Bun-ichiro NAKAJIMA, Akihiro TSUTSUMI, and Norio NISHI Department of Polymer Science, Faculty of Science, Hokkaido University, Nishi 8-chome, Kita 10-jo, Kita-ku, Sapporo 060, Japan. (Received August 14, 1981) KEY WORDS Polymerization I Diphenylphosphoryl Azide (DPPA) I L- Histidine I N'm-Benzyl-L-histidine I Poly(L-histidine) I Poly(N'm-benzyl-L­ histidine) I IR Spectrum I 13C NMR Spectrum I Intrinsic Viscosity I Poly(L-histidine) is a very interesting poly(a­ histidine) by the polymerization of L-histidine with amino acid) as a synthetic functional polymer or as iodine-phosphonic acid esters was unsuccessful. The a model for the functional biopolymer such as simplification of the synthetic route for poly(L­ enzymes. It is known, however, that poly(L­ histidine) is still necessary. histidine) can not be prepared by the Fuchs­ Diphenylphosphoryl azide (DPPA) has been used Farthing method 1 which is very popular for prepar­ as a convenient reagent for racemization-free pep­ ing poly(a-amino acid)s. A synthetic route with tide synthesis, since it was synthesized by Shioiri et several steps involving the synthesis of NCA (a­ a!. in 1972.6 Recently, we reported that this reagent amino acid N-carboxyanhydride) by the rather can also be used successfully for the polymerization classical Leuchs method/ have been used for the of amino acids or peptides.
    [Show full text]